Not finding it? Sign in to also search OpenAlex live.
-
Treatment sequence with gilteritinib and allogeneic haematopoietic stem cell transplantation in relapsed/refractory FMS‐like tyrosine kinase 3 ( FLT3 )‐mutated acute myeloid leukaemia patients: A multicentre real‐world study
Desireé Kunadt, Sven Zukunft, Christoph Röllig, S K Metzelder, Andreas Burchert, Eva Wagner‐Drouet, +50 more
0citations -
Complex karyotype but not other cytogenetic abnormalities is associated with worse posttransplant survival of patients with nucleophosmin 1‐mutated acute myeloid leukemia: A study from the European Society for Blood and Marrow Transplantation Acute Leukemia Working Party
Nour M. Moukalled, Myriam Labopin, Jurjen Versluis, Gèrard Socié, Didier Blaise, Urpu Salmenniemi, +12 more
7citations -
Should the European Leukemia Net 2022 Adverse Risk Classification of NPM1 mutated Acute Myeloid Leukemia be Revisited? Among Adverse Risk Cytogenetics, Solely Complex Karyotype Is Associated with Worse Post-Transplant Survival: A Study from the EBMT Acute Leukemia Working Party
Nour M. Moukalled, Myriam Labopin, Jurjen Versluis, Gèrard Socié, Didier Blaise, Urpu Salmenniemi, +12 more
0citations -
Oncostatin M induced by STAT5-activating oncogenes promotes disease progression in hematologic malignancies2025 Signal Transduction and Targeted Therapy article Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access
Michael P. Rassner, Tony Andreas Müller, Kirstyn Anne Crossley, Geoffroy Andrieux, Sabina Schaberg, Cornelia Endres, +19 more
1citations -
Cytogenetic and molecular risk-driven conditioning intensity in acute myeloid leukemia patients undergoing stem cell transplantation with post-transplant cyclophosphamide: a study from the acute leukemia working party of the EBMT2025 Bone Marrow Transplantation article Medicine Hematopoietic Stem Cell Transplantation Open access
Jaime Sanz, Myriam Labopin, Jurjen Versluis, Didier Blaise, Lorenzo Lazzari, Juan Montoro, +14 more
5citations -
Trends in allogeneic transplantation for favorable risk acute myeloid leukemia in first remission: a longitudinal study of >15 years from the ALWP of the EBMT2024 Bone Marrow Transplantation article Medicine Hematopoietic Stem Cell Transplantation Open access
Arnon Nagler, Myriam Labopin, Urpu Salmenniemi, Depei Wu, Didier Blaise, Alessandro Rambaldi, +15 more
3citations -
Trends in Allogeneic Transplantation for Favorable Risk Acute Myeloid Leukemia in First Complete Remission: A Longitudinal Study of > 15 Years from the ALWP/EBMT2024 Transplantation and Cellular Therapy article Medicine Acute Myeloid Leukemia Research Open access
Arnon Nagler, Myriam Labopin, Urpu Salmenniemi, Depei Wu, Didier Blaise, Alessandro Rambaldi, +15 more
0citations -
Allogeneic Stem Cell Transplantation for Patients with Acute Myeloid Leukemia with Myelodysplasia-Related Features in First Complete Remission As per the International Consensus Classification (ICC) 2022: A Study from the ALWP of the EBMT2024 Transplantation and Cellular Therapy article Medicine Acute Myeloid Leukemia Research Open access
Arnon Nagler, Myriam Labopin, Jurjen Versluis, Jaime Sanz, Tobias Gedde‐Dahl, David Burns, +11 more
1citations
23 results